AGLE Earnings Date

Report Date	Period Ending	EPS Forecast	Last Quarter's EPS	Last Year's EPS
Mar 16, 2022	Dec 2021	$-0.29	$-0.31	$-0.34

Report Date	Period Ending	Revenue Forecast	Last Quarter’s Revenue	Last Year’s Revenue
Mar 16, 2022	Dec 2021	$2.46M	$1.40M	$0.00

Aeglea Biotherapeutics's next earnings date is Wednesday, Mar 16, 2022 for the fiscal quarter ending Dec 2021.

AGLE Earnings Date & History Chart

AGLE Earnings & Revenue Forecast

AGLE Earnings Forecast

Period End	# of Analysts	EPS Forecast	Low EPS Forecast	High EPS Forecast
Mar 2022	4	$-0.33	$-0.36	$-0.30

Period End	# of Analysts	EPS Forecast	Low EPS Forecast	High EPS Forecast
Dec 2022	8	$-0.97	$-1.57	$0.56

AGLE Earnings Revision Trend

Period End	Up/Down 1M	1M Trend	2M Trend	3M Trend
Mar 2022	0 / 0	$-0.33	$-0.33	$-0.33

Period End	Up/Down 1M	1M Trend	2M Trend	3M Trend
Dec 2022	0 / 0	$-0.97	$-0.96	$-0.96

AGLE Revenue Forecast

Period End	# of Analysts	Revenue Forecast	Low Revenue Forecast	High Revenue Forecast
Mar 2022	2	$700.00K	$0.00	$1.40M

Period End	# of Analysts	EPS Forecast	Low EPS Forecast	High EPS Forecast
Dec 2022	5	$7.58M	$0.00	$27.30M

AGLE Earnings Date & Revenue History

AGLE Earnings History

Report Date	Period Ending	Forecast EPS	Actual EPS	Surprise
Mar 16, 2022	Dec 2021	$-0.29	-	-
Nov 4, 2021	Sep 2021	$-0.29	$-0.31	-5.62%
Aug 5, 2021	Jun 2021	$-0.17	$-0.10	41.86%
May 10, 2021	Mar 2021	$-0.14	$-0.28	-100.57%
Mar 18, 2021	Dec 2020	$-0.33	$-0.34	-2.63%
Nov 5, 2020	Sep 2020	$-0.40	$-0.29	27.26%
Aug 10, 2020	Jun 2020	$-0.43	$-0.40	7.06%
May 7, 2020	Mar 2020	$-0.66	$-0.57	13.19%
Feb 24, 2020	Dec 2019	$-0.66	$-0.65	2.15%
Nov 6, 2019	Sep 2019	$-0.53	$-0.66	-23.99%
Aug 6, 2019	Jun 2019	$-0.48	$-0.55	-13.82%
May 7, 2019	Mar 2019	$-0.55	$-0.59	-6.85%
Mar 7, 2019	Dec 2018	$-0.37	$-0.62	-69.35%
Nov 8, 2018	Sep 2018	$-0.43	$-0.54	-25.00%
Aug 9, 2018	Jun 2018	$-0.35	$-0.46	-33.33%
May 8, 2018	Mar 2018	$-0.46	$-0.49	-6.41%
Mar 13, 2018	Dec 2017	$-0.53	$-0.39	26.25%
Nov 7, 2017	Sep 2017	$-0.55	$-0.48	12.89%
Aug 9, 2017	Jun 2017	$-0.48	$-0.47	2.08%
May 9, 2017	Mar 2017	$-0.47	$-0.47	-0.45%
Mar 23, 2017	Dec 2016	$-0.51	$-0.33	35.31%
Nov 9, 2016	Sep 2016	$-0.54	$-0.47	13.57%
Aug 9, 2016	Jun 2016	$-0.42	$-0.46	-9.52%
May 19, 2016	Mar 2016	$-0.49	$-0.35	27.63%

Report Date	Period Ending	Forecast EPS	Actual EPS	Surprise
Mar 16, 2022	Dec 2021	$-0.98	$-0.69	-
Mar 18, 2021	Dec 2020	$-1.50	$-1.60	-
Feb 24, 2020	Dec 2019	$-2.48	$-2.45	-
Mar 7, 2019	Dec 2018	$-1.84	$-2.11	-
Mar 13, 2018	Dec 2017	$-1.95	$-1.81	-
Mar 23, 2017	Dec 2016	-	$-1.61	-

AGLE Revenue History

Report Date	Period Ending	Forecast Revenue	Actual Revenue	Surprise
Mar 16, 2022	Dec 2021	$2.46M	-	-
Nov 4, 2021	Sep 2021	$4.05M	$1.40M	0.35%
Aug 5, 2021	Jun 2021	$12.15M	$13.70M	1.13%
May 10, 2021	Mar 2021	$13.00M	$0.00	-
Mar 18, 2021	Dec 2020	$0.00	$0.00	-
Nov 5, 2020	Sep 2020	$0.00	$0.00	-
Aug 10, 2020	Jun 2020	$0.00	$0.00	-
May 7, 2020	Mar 2020	$3.36M	$0.00	-
Feb 24, 2020	Dec 2019	$0.00	$0.00	-
Nov 6, 2019	Sep 2019	$0.00	$0.00	-
Aug 6, 2019	Jun 2019	$300.00K	$0.00	-
May 7, 2019	Mar 2019	$300.00K	$0.00	-
Mar 7, 2019	Dec 2018	$1.98M	$3.89M	1.96%
Nov 8, 2018	Sep 2018	$1.16M	$2.38M	2.05%
Aug 9, 2018	Jun 2018	$1.63M	$2.38M	1.46%
May 8, 2018	Mar 2018	$1.07M	$1.51M	1.41%
Mar 13, 2018	Dec 2017	$1.16M	$1.48M	1.28%
Nov 7, 2017	Sep 2017	-	$1.26M	-
Aug 9, 2017	Jun 2017	-	$1.48M	-
May 9, 2017	Mar 2017	-	$982.00K	-
Mar 23, 2017	Dec 2016	-	$1.25M	-
Nov 9, 2016	Sep 2016	-	$1.15M	-
Aug 9, 2016	Jun 2016	-	$1.37M	-
May 19, 2016	Mar 2016	-	$859.00K	-

Report Date	Period Ending	Forecast Revenue	Actual Revenue	Surprise
Mar 16, 2022	Dec 2021	$18.30M	-	-
Mar 18, 2021	Dec 2020	$0.00	$21.84K	-
Feb 24, 2020	Dec 2019	$0.00	$0.00	-
Mar 7, 2019	Dec 2018	$4.49M	$3.89M	-13.41%
Mar 13, 2018	Dec 2017	$4.88M	$5.21M	6.66%
Mar 23, 2017	Dec 2016	-	$4.63M	-

Aeglea Biotherapeutics Next Earnings Date & Report

AGLE Next Earnings Date & Report Preview: Dec 2021 (FQ)

AGLE's next earnings date is Wednesday, Mar 16, 2022 for the fiscal quarter ending Dec 31, 2021.

According to 7 analysts, the average EPS estimation for Aeglea Biotherapeutics's next quarterly earnings is $-0.29, with a low EPS estimation of $-0.34, and a high estimation of $-0.17.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.29, the last 2 month trend is $-0.31, and the 3 month trend is $-0.31.

Based on 5 analysts, the average revenue estimation is $2.46M, with a low revenue estimation of $0.00, and a high estimation of $9.50M.

Aeglea Biotherapeutics Previous Earnings Dates & Reports

AGLE Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Aeglea Biotherapeutics's previous earnings date was Nov 4, 2021 for its fiscal quarter ended Sep 30, 2021.

AGLE's earnings per share (EPS) was $-0.31, missing the consensus analysts forecast of $-0.29 by -5.62%.

The EPS was lower than the previous fiscal quarter (Jun 2021) by 210.00%, and lower than the same period a year before (Sep 2020) by 6.90%.

Revenues were $1.40M.

The company reported a net income of $-20.31M.

Free cash flow for the quarter was $-17.09M , compared to $2.05M last quarter and $-18.10M a year before.

AGLE ended the quarter with $5.16M in total debt, a decrease of -2.48% compared to the previous quarter, and a decrease of -2.40% compared to the same quarter a year before.

AGLE Previous Earnings Date & Report Recap: Dec 2020 (FY)

Aeglea Biotherapeutics's previous annual earnings date was Mar 18, 2021 for its fiscal year ended Dec 31, 2020.

AGLE's earnings per share (EPS) was $-1.60, missing the consensus analysts forecast of $-1.50 by 6.67% , and higher than the previous year's EPS (Dec 2019) by -34.69%.

Revenues were $21.84K.

The company reported a net income of $-80.89M.

Aeglea Biotherapeutics reported a free cash flow of $-80.06M for its fiscal year, compared to $-67.18M a year ago.

The company ended the fiscal year with $5.45M in total debt, an increase of 7.60% compared to the previous year.

Aeglea BioTherapeutics Earning Date (AGLE)